-
Signature
-
/s/ Jonathan Isler, Attorney-in-Fact
-
Stock symbol
-
LRMR
-
Transactions as of
-
May 29, 2024
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
6/3/2024, 06:31 PM
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
LRMR |
Stock Option (Right to Buy) |
Award |
$0 |
+19K |
|
$0.00 |
19K |
May 29, 2024 |
Common Stock |
19K |
$7.07 |
Through Deerfield Management Company, L.P. |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Jonathan S. Leff, a partner in Deerfield Management, serves as a director of the Issuer. Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to BiomX Inc. filed with the Securities and Exchange Commission on March 19, 2024 by Deerfield Private Design Fund V, L.P., Deerfield Healthcare Innovations Fund II, L.P., Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P., Deerfield Management Company, L.P. and James E. Flynn.